Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Aeglea Biotherapeutics (AGLE) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 22 quarters since 2016. Compare with AGLE stock chart to see long term trends.

AGLE stock compared to

AGLE Income Statement

Revenue, Net:13696000
Revenue Per Share:0.21
Research & Development Expense:13579000
Total Operating Expenses:20401000
Operating Income:-6738000
Income Taxes:92000
Net Income:-6830000
Earnings Per Share, Basic:-0.1
Shares Outstanding, Basic Avg:65631906

AGLE Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:398000
Change in Accounts Receiveable:null
Net Cash from Operations:2082000
Net Cash from Financing Activities:-192000
Property, Plant & Equipment Purchases:30000
Net Cash from Investing Activities:-47359000
Net Change in Cash & Equivalents:-45465000

AGLE Balance Sheet

Cash and Cash Equivalents:36611000
Total Current Assets:134368000
Property, Plant & Equipment, Net:5208000
Total Assets:146982000
Accounts Payable:2221000
Total Short-Term Liabilities:20604000
Total Liabilities:27958000

Insider Trading

Change
Value
Transaction
SEC Form 4
Alspaugh Jonathan   Chief Financial Officer
40,372 sh at $7
$262,660
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Orbimed Advisors LLC
4,015,524 sh
 
$27,948
Baker Bros. Advisors Lp
3,410,106 sh
 
$23,734
Blackrock Inc.
3,103,879 sh
-246,433 sh
-7%
$21,605
-$4,929
Adage Capital Partners Gp, L.L.C.
3,049,581 sh
101,440 sh
3%
$21,225
-$2,124
Bain Capital Life Sciences Investors, LLC
2,700,000 sh
 
$18,792
Pictet Asset Management Ltd
2,532,799 sh
13,465 sh
1%
$17,628
-$2,325
Vanguard Group Inc
2,097,166 sh
-76,896 sh
-4%
$14,596
-$2,623
Suvretta Capital Management, LLC
2,094,100 sh
727,027 sh
53%
$14,575
$3,748
Aisling Capital Management Lp
1,691,151 sh
 
$11,770
Nantahala Capital Management, LLC
1,677,036 sh
-35,052 sh
-2%
$11,672
-$1,888
Rock Springs Capital Management Lp
1,577,296 sh
 
$10,978
Goldman Sachs Group Inc
1,131,059 sh
-5,614 sh
0%
$7,873
-$1,129
Artal Group S.A.
1,045,000 sh
 
$7,273
Great Point Partners LLC
900,000 sh
397,100 sh
79%
$6,264
$2,281
Samsara Biocapital, LLC
883,720 sh
 
$6,151
State Street Corp
757,500 sh
39,025 sh
5%
$5,272
-$418
Geode Capital Management, LLC
677,726 sh
19,856 sh
3%
$4,716
-$494
Marshall Wace, Llp
651,403 sh
-539,836 sh
-45%
$4,534
-$4,901
Altium Capital Management Lp
609,689 sh
341,936 sh
128%
$4,243
$2,122
Dimensional Fund Advisors LP
604,112 sh
10,695 sh
2%
$4,205
-$489

Data imported from Aeglea Biotherapeutics Inc SEC filings. Check original filings before making any investment decision.